Envoy Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	0.3	0.32	0.24	0.31
Revenue Growth (YoY)	38.79%	33.33%	-23.55%	-
Cost of Revenue	0.77	0.79	0.5	0.77
Gross Profit	-0.47	-0.47	-0.26	-0.46
Selling, General & Admin	9.64	8.94	3.47	2.47
Research & Development	9.39	8.96	4.98	3.94
Operating Expenses	19.03	17.9	8.45	6.41
Operating Income	-19.5	-18.37	-8.71	-6.87
Interest Expense	-0.04	-	-	-
Other Non Operating Income (Expenses)	9.94	1.8	-0.13	-1.8
EBT Excluding Unusual Items	-9.59	-16.58	-8.83	-8.67
Gain (Loss) on Sale of Assets	-	-	-	-0
Other Unusual Items	-13.33	-13.33	-7.09	-
Pretax Income	-22.93	-29.91	-15.92	-8.68
Net Income	-22.93	-29.91	-15.92	-8.68
Net Income to Common	-22.93	-29.91	-15.92	-8.68
Shares Outstanding (Basic)	15	13	10	10
Shares Outstanding (Diluted)	15	13	10	10
Shares Change (YoY)	-89.28%	24.00%	-0.04%	-
EPS (Basic)	-1.54	-2.38	-1.57	-0.86
EPS (Diluted)	-1.54	-2.38	-1.57	-0.86
Free Cash Flow	-20.58	-17.81	-9.02	-7.06
Free Cash Flow Per Share	-1.38	-1.42	-0.89	-0.70
Gross Margin	-158.25%	-149.68%	-110.13%	-148.06%
Operating Margin	-6564.98%	-5813.61%	-3673.42%	-2216.45%
Free Cash Flow Margin	-6930.30%	-5635.13%	-3807.17%	-2277.74%
EBITDA	-19.36	-18.24	-8.63	-6.8
D&A For EBITDA	0.14	0.13	0.08	0.07
EBIT	-19.5	-18.37	-8.71	-6.87

Source: S&P Capital IQ. Standard template.